GLP-1/GIP Injections
The dual-hormone approach that changes everything.
GLP-1/GIP combination therapy represents the cutting edge of metabolic medicine. By targeting two distinct hormone pathways simultaneously — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) — this treatment delivers superior appetite control, faster weight loss, and better metabolic outcomes than single-hormone therapies alone. This is the science behind Mounjaro and Zepbound, compounded for personalized dosing.
Key Benefits
- ✓Clinically proven average weight loss of 15–22%
- ✓Significantly reduced appetite and cravings
- ✓Improved blood sugar control
- ✓Better cardiovascular risk markers
- ✓Reduced inflammation systemically
- ✓Superior efficacy vs. GLP-1 monotherapy
Quick Facts
GLP-1 receptors in the gut and brain slow gastric emptying, reduce appetite signals, and improve insulin secretion. GIP adds complementary action: it enhances the glucose-lowering effect of GLP-1, reduces glucagon secretion, and may directly affect fat cell metabolism. Together, they produce a coordinated metabolic response that makes you feel full sooner, stay full longer, and process the food you do eat more efficiently. Most patients see significant weight loss within the first 8–12 weeks.
More from Weight Loss
You Might Also Like
All prescription treatments require approval from a licensed healthcare provider. Results may vary. This product has not been evaluated by the FDA for the specific indications described. Reclaimed is a telehealth platform — we facilitate connections between patients and licensed providers, not the practice of medicine directly. Please consult your provider with any questions about your treatment.